Redwood Investment Management, LLC Exelixis, Inc. Transaction History

Redwood Investment Management, LLC

  • $1.13 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$20.17 - $23.93 $97,663 - $115,869
4,842 Added 8.27%
63,380 $1.5 Million
Q4 2023

Feb 14, 2024
SELL
$19.25 - $24.13 $260,086 - $326,020
-13,511 Reduced 18.75%
58,538 $1.4 Million
Q3 2023

Nov 14, 2023
BUY
$19.04 - $22.74 $1.37 Million - $1.64 Million
72,049 New
72,049 $1.57 Million

Others Institutions Holding EXEL

# of Institutions
541
Shares Held
245M
Call Options Held
2.84M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.8B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Redwood Investment Management, LLC Portfolio

Follow Redwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email